, Tracking Stock Market Picks
Enter Symbol:
Rating: MNKD
Hold $11

Mannkind Corporation (NASDAQ: MNKD) downgraded to Hold with price target $11 by MLV & Co

Tuesday,  Jul 1, 2014  12:00 AM ET by Dave Ficere

MLV & Co downgraded Mannkind Corporation (NASDAQ: MNKD) to Hold with price
target $11. Previously MLV & Co rated Buy with price target $8 Mannkind Corporation (NASDAQ: MNKD) on 06/27/2013, when the stock price was $6.55.

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

MLV & Co is a boutique investment bank and institutional broker-dealer focused on providing independent financial advice and unique capital markets expertise to corporate and institutional clients in capital intensive industries such as metals and mining, life sciences, energy and real estate. With a focus on raising money efficiently for clients, MLV has rapidly become a leader in the At-the-Market(ATM) transaction market.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy